Literature DB >> 31792078

Major Histocompatibility Complex Class II-Restricted, CD4+ T Cell-Dependent and -Independent Mechanisms Are Required for Vaccine-Induced Protective Immunity against Coxiella burnetii.

Lindsey Ledbetter1, Rama Cherla1, Catherine Chambers1, Yan Zhang1,2, William J Mitchell1, Guoquan Zhang3,2.   

Abstract

To understand the role of major histocompatibility complex class I (MHC-I) and MHC-II in vaccine-mediated protection against Coxiella burnetii, we evaluated the protective efficacy of a formalin-inactivated C. burnetii Nine Mile phase I vaccine (PIV) in β2-microglobulin-deficient (B2m KO) and MHC-II-deficient (MHC-II KO) mice. Vaccination reduced disease severity in wild-type (WT) and B2m KO mice but failed to reduce bacterial burden in MHC-II KO mice. This suggests that the MHC-II antigen presentation pathway is required for PIV-mediated protection against C. burnetii infection. MHC-I and MHC-II affect antibody isotype switching, since both PIV-vaccinated B2m KO and MHC-II KO mice produced less Coxiella-specific IgG than PIV-vaccinated WT mice. Interestingly, MHC-II and CD4 deficiencies were not equivalent in terms of splenomegaly and bacterial clearance. This demonstrates a partial role for CD4+ T cells while revealing MHC-II-restricted, CD4-independent mechanisms. Adoptive transfer of CD4+ T cells from PIV-vaccinated WT mice to naive CD4-deficient (CD4 KO) mice demonstrated that antigen-experienced CD4+ T cells are sufficient to generate protection. Conversely, transfer of naive CD4+ T cells to PIV-vaccinated CD4 KO mice exacerbates disease. Using Tbet-deficient (Tbet KO) mice, we showed a partial role for Th1 subset CD4+ T cells in vaccine protection. Furthermore, Th1-independent roles for Tbet were suggested by significant differences in disease between PIV-vaccinated Tbet KO and CD4 KO mice. Interferon gamma was shown to contribute to the host inflammatory response but not bacterial clearance. Collectively, these findings suggest that vaccine-induced protective immunity against a murine model of experimental Q fever requires MHC-II-restricted, CD4+ T cell-dependent and -independent mechanisms that can be exploited for a new-generation human Q fever vaccine.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  CD4+ T cells; Coxiella burnetiizzm321990; IFN-γ; Tbet-deficient mice; Th1 response; major histocompatibility complex; vaccine-induced immunity

Mesh:

Substances:

Year:  2020        PMID: 31792078      PMCID: PMC7035945          DOI: 10.1128/IAI.00824-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  87 in total

1.  Functional characterization of MHC class II-restricted CD8+CD4- and CD8-CD4- T cell responses to infection in CD4-/- mice.

Authors:  Erika L Pearce; Devon J Shedlock; Hao Shen
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

Review 2.  Components of protective immunity.

Authors:  Guoquan Zhang; Yan Zhang; James E Samuel
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 3.  Q fever: the neglected biothreat agent.

Authors:  P C F Oyston; C Davies
Journal:  J Med Microbiol       Date:  2010-10-28       Impact factor: 2.472

4.  Q-fever patients suffer from impaired health status long after the acute phase of the illness: results from a 24-month cohort study.

Authors:  Joris A F van Loenhout; Jeannine L A Hautvast; Jan H Vercoulen; Reinier P Akkermans; Clementine J Wijkmans; Koos van der Velden; W John Paget
Journal:  J Infect       Date:  2014-11-01       Impact factor: 6.072

5.  Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine.

Authors:  A A Izzo; B P Marmion; D A Worswick
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

6.  A randomized, controlled, double-blind, cross-over, clinical trial of Q fever vaccine in selected Queensland abattoirs.

Authors:  R A Shapiro; V Siskind; F D Schofield; N Stallman; D A Worswick; B P Marmion
Journal:  Epidemiol Infect       Date:  1990-04       Impact factor: 2.451

Review 7.  Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation.

Authors:  Shane Crotty; Robert J Johnston; Stephen P Schoenberger
Journal:  Nat Immunol       Date:  2010-01-19       Impact factor: 25.606

8.  Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice.

Authors:  R M Locksley; S L Reiner; F Hatam; D R Littman; N Killeen
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

9.  Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine.

Authors:  D Raoult; P Houpikian; H Tissot Dupont; J M Riss; J Arditi-Djiane; P Brouqui
Journal:  Arch Intern Med       Date:  1999-01-25

10.  Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent.

Authors:  Jeffrey G Shannon; Diane C Cockrell; Kazue Takahashi; Gregory L Stahl; Robert A Heinzen
Journal:  BMC Immunol       Date:  2009-05-08       Impact factor: 3.615

View more
  7 in total

Review 1.  Immunogenicity and Reactogenicity in Q Fever Vaccine Development.

Authors:  Alycia P Fratzke; Erin J van Schaik; James E Samuel
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

2.  Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity.

Authors:  Ann E Sluder; Susan Raju Paul; Leonard Moise; Christina Dold; Guilhem Richard; Laura Silva-Reyes; Laurie A Baeten; Anja Scholzen; Patrick M Reeves; Andrew J Pollard; Anja Garritsen; Richard A Bowen; Anne S De Groot; Christine Rollier; Mark C Poznansky
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

3.  Failure of CD4 T Cell-Deficient Hosts To Control Chronic Nontyphoidal Salmonella Infection Leads to Exacerbated Inflammation, Chronic Anemia, and Altered Myelopoiesis.

Authors:  Wendy P Loomis; Martha A Delaney; Matthew L Johnson; Brad T Cookson
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

4.  Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity.

Authors:  Carrie M Long; Paul A Beare; Diane C Cockrell; Jonathan Fintzi; Mahelat Tesfamariam; Carl I Shaia; Robert A Heinzen
Journal:  NPJ Vaccines       Date:  2021-03-19       Impact factor: 7.344

5.  The Feasibility of Using Coxiella burnetii Avirulent Nine Mile Phase II Viable Bacteria as a Live Attenuated Vaccine Against Q fever.

Authors:  Venkatesh Kumaresan; Shawkat Alam; Yan Zhang; Guoquan Zhang
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

Review 6.  Virus Detection: From State-of-the-Art Laboratories to Smartphone-Based Point-of-Care Testing.

Authors:  Meng Xiao; Feng Tian; Xin Liu; Qiaoqiao Zhou; Jiangfei Pan; Zhaofan Luo; Mo Yang; Changqing Yi
Journal:  Adv Sci (Weinh)       Date:  2022-04-07       Impact factor: 17.521

7.  Cross-reactivity between vaccine antigens from the chitin deacetylase protein family improves survival in a mouse model of cryptococcosis.

Authors:  Maureen M Hester; Lorena V N Oliveira; Ruiying Wang; Zhongming Mou; Diana Lourenco; Gary R Ostroff; Charles A Specht; Stuart M Levitz
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.